Search by Drug Name or NDC
NDC 00363-0310-34 wal tussin 200 mg/10mL Details
wal tussin 200 mg/10mL
wal tussin is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 00363-0310-34Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 00363-0310 |
|---|---|
| Product ID | 0363-0310_74975388-34c0-4c4e-8368-8e375efe7908 |
| Associated GPIs | 43200010001210 |
| GCN Sequence Number | 022210 |
| GCN Sequence Number Description | guaifenesin LIQUID 100 MG/5ML ORAL |
| HIC3 | B3J |
| HIC3 Description | EXPECTORANTS |
| GCN | 02512 |
| HICL Sequence Number | 000271 |
| HICL Sequence Number Description | GUAIFENESIN |
| Brand/Generic | Generic |
| Proprietary Name | wal tussin |
| Proprietary Name Suffix | adult chest congestion |
| Non-Proprietary Name | Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/10mL |
| Substance Name | GUAIFENESIN |
| Labeler Name | Walgreen Company |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00363-0310-34 (00363031034)
| NDC Package Code | 0363-0310-34 |
|---|---|
| Billing NDC | 00363031034 |
| Package | 1 BOTTLE in 1 CARTON (0363-0310-34) / 237 mL in 1 BOTTLE |
| Marketing Start Date | 1995-10-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |